Skip to content

A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population

A Pilot Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease/ Peripheral Artery Disease (CAD/PAD) Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06052319
Acronym
IPACE-CVD
Enrollment
277
Registered
2023-09-25
Start date
2023-11-29
Completion date
2024-08-13
Last updated
2025-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD)

Keywords

Care4Today, Coronary Artery Disease, Peripheral Artery Disease, CAD, PAD

Brief summary

The purpose of this study is to assess the engagement and usefulness of Care4Today® Connect CAD-PAD digital platform in participants with coronary artery disease or peripheral artery disease (CAD or PAD).

Interventions

DEVICECare4Today® Connect CAD-PAD Mobile Application

Participants will not receive any drug intervention in this study. Participants will use Care 4Today® Connect CAD-PAD mobile application for 3 months. The study will assess participant engagement and usefulness.

Sponsors

HCA Research Institute, LLC
CollaboratorUNKNOWN
Janssen Scientific Affairs, LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Must have a diagnosis of CAD and or PAD, who are on therapy or about to initiate therapy * Own an iPhone or Android mobile device * Have an active email account * Must sign a participation agreement or informed consent form (ICF) allowing data collection in accordance with local requirements * Willing to download and use Care4Today (C4T) CAD-PAD application (app)

Exclusion criteria

* Any cardiovascular conditions (for example, recent stroke, high bleeding risk, severe heart failure) or non-cardiovascular condition deemed as poor prognosis by the investigator and which may percent a patient from completing the study * Unable to read or write the language used for the C4T (English, or Spanish if Spanish version is available) * Visual or hearing impairment or mental disability that would preclude independent app use * Patients currently using the C4T app prior to the signing of ICF

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants Who use the Care4Today (C4T) Coronary Artery Disease-Peripheral Artery Disease (CAD-PAD) Application for at Least 10 Weeks During the 3-Month Study PeriodUp to 3 monthsPercentage of participants (of those who onboarded the C4T CAD-PAD app) who use CAD-PAD the application for at least 10 weeks during the 3-month study period will be reported. The weekly app use is defined as using at least one component of the app once a week.
Percentage of Engaged Participants who Complete End of Study Survey with Satisfaction Response Score of Greater Than or Equal to (>=) 2 for at Least 3 QuestionsUp to 3 monthsPercentage of engaged participants who complete end of study survey with satisfaction response score of \>= 2 for at least 3 questions (out of 6 total questions) will be reported. Satisfaction survey consists of six questions in the end of study - each with 5 possible responses on a likert scale (1-5). The lowest possible response to any question is 1 =disagree and the highest possible response to any question is 5 = agree. Higher response on this scale represents more agreement or satisfaction.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026